[1]
Druce, I. 2023. Endocrinopathies Associated with Immune Checkpoint Inhibitors. Canadian Diabetes & Endocrinology Today. 1, 2 (Jun. 2023), 5–8. DOI:https://doi.org/10.58931/cdet.2023.1210.